Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Science 37 Hldgs Inc (SNCE)

Science 37 Hldgs Inc (SNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Science 37 Hldgs Inc 800 PARK OFFICES DRIVE SUITE 3606 NORTH CAROLINA NC 27709 USA

www.science37.com P: 984-377-3737

Description:

Science 37 Inc. provides operating system for agile clinical trials. Science 37 Inc., formerly known as LifeSci Acquisition II Corp., is based in LOS ANGELES.

Key Statistics

Overview:

Market Capitalization, $K 34,327
Enterprise Value, $K -73,763
Shares Outstanding, K 5,970
Annual Sales, $ 70,150 K
Annual Net Income, $ -50,990 K
Last Quarter Sales, $ 14,890 K
Last Quarter Net Income, $ -13,920 K
EBIT, $ -76,970 K
EBITDA, $ -59,030 K
60-Month Beta 0.55
% of Insider Shareholders 6.80%
% of Institutional Shareholders 40.67%
Float, K 5,564
% Float 93.20%
Short Volume Ratio 0.69

Growth:

1-Year Return 20.24%
3-Year Return -97.25%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.00 on 11/07/23
Latest Earnings Date 03/18/24
Earnings Per Share ttm -10.40
EPS Growth vs. Prev Qtr 20.00%
EPS Growth vs. Prev Year 61.90%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 12/08/23

SNCE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -83.09%
Return-on-Assets % -61.58%
Profit Margin % -72.69%
Debt/Equity 0.00
Price/Sales 0.56
Price/Cash Flow N/A
Price/Book 0.66
Book Value/Share 8.67
Interest Coverage -31.05
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar